Stay updated on Elranatamab vs Lenalidomide Post-Transplant Clinical Trial
Sign up to get notified when there's something new on the Elranatamab vs Lenalidomide Post-Transplant Clinical Trial page.

Latest updates to the Elranatamab vs Lenalidomide Post-Transplant Clinical Trial page
- Check6 days agoChange DetectedNew study site added: Wroclaw, Poland (52-007). Recruitment status updated to Active, not recruiting as of 2025-12-04.SummaryDifference0.4%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe study's recruitment locations have been updated to 217, with the removal of O'Brien Pharmacy (Mission, KS) and American Oncology Partners dba MidAmerica Cancer Care (Merriam, KS). Related topics now include Multiple Myeloma and MedlinePlus Genetics.SummaryDifference0.7%

- Check28 days agoChange DetectedStudy record status updated to Active, not recruiting. Revision dates 2025-11-11 and 2025-11-13 were added to the page history.SummaryDifference0.3%

- Check49 days agoChange DetectedThe two screenshots show no substantive changes to study details; only minor cosmetic/layout adjustments are visible. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check56 days agoChange DetectedThe page updates replace several U.S. clinical site listings and a prior total of 223 locations with new 2025-10-20 additions, a new count of 219 locations, and new Yamagata, Japan details, plus new timestamps like 2025-10-17 and 2025-10-20.SummaryDifference4%

- Check63 days agoChange Detected- Added: MedlinePlus Genetics topic on multiple myeloma. - No deletions.SummaryDifference0.1%

Stay in the know with updates to Elranatamab vs Lenalidomide Post-Transplant Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Elranatamab vs Lenalidomide Post-Transplant Clinical Trial page.